CN109839349A - 检测液体相变的装置和方法 - Google Patents
检测液体相变的装置和方法 Download PDFInfo
- Publication number
- CN109839349A CN109839349A CN201711210942.2A CN201711210942A CN109839349A CN 109839349 A CN109839349 A CN 109839349A CN 201711210942 A CN201711210942 A CN 201711210942A CN 109839349 A CN109839349 A CN 109839349A
- Authority
- CN
- China
- Prior art keywords
- sample
- deposition
- detection
- pressure
- pipeline
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000007788 liquid Substances 0.000 title claims abstract description 74
- 238000000034 method Methods 0.000 title claims abstract description 64
- 238000001514 detection method Methods 0.000 claims abstract description 120
- 230000008021 deposition Effects 0.000 claims abstract description 98
- 239000012530 fluid Substances 0.000 claims abstract description 48
- 230000008569 process Effects 0.000 claims abstract description 41
- 230000007704 transition Effects 0.000 claims abstract description 21
- 210000004369 blood Anatomy 0.000 claims description 56
- 239000008280 blood Substances 0.000 claims description 56
- 239000012071 phase Substances 0.000 claims description 36
- 230000009466 transformation Effects 0.000 claims description 16
- 238000004891 communication Methods 0.000 claims description 5
- 238000006116 polymerization reaction Methods 0.000 claims description 4
- 108090000623 proteins and genes Proteins 0.000 claims description 4
- 102000004169 proteins and genes Human genes 0.000 claims description 4
- 239000007791 liquid phase Substances 0.000 claims description 3
- 208000007536 Thrombosis Diseases 0.000 description 27
- 238000007711 solidification Methods 0.000 description 19
- 230000008023 solidification Effects 0.000 description 19
- 238000012360 testing method Methods 0.000 description 15
- 239000007787 solid Substances 0.000 description 13
- 230000008859 change Effects 0.000 description 11
- 230000023555 blood coagulation Effects 0.000 description 9
- 238000010586 diagram Methods 0.000 description 8
- 230000000052 comparative effect Effects 0.000 description 7
- 239000000463 material Substances 0.000 description 7
- 210000001772 blood platelet Anatomy 0.000 description 6
- 239000003814 drug Substances 0.000 description 6
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 5
- 239000004926 polymethyl methacrylate Substances 0.000 description 5
- 230000015572 biosynthetic process Effects 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 230000001939 inductive effect Effects 0.000 description 4
- 210000002381 plasma Anatomy 0.000 description 4
- 238000012545 processing Methods 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 239000010935 stainless steel Substances 0.000 description 4
- 229910001220 stainless steel Inorganic materials 0.000 description 4
- 208000032843 Hemorrhage Diseases 0.000 description 3
- 241001494479 Pecora Species 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 230000000740 bleeding effect Effects 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 230000008676 import Effects 0.000 description 3
- -1 poly- acetyl lactones Chemical class 0.000 description 3
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 3
- 239000004810 polytetrafluoroethylene Substances 0.000 description 3
- 238000005070 sampling Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 2
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 2
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 2
- 108010010803 Gelatin Proteins 0.000 description 2
- 241000209094 Oryza Species 0.000 description 2
- 235000007164 Oryza sativa Nutrition 0.000 description 2
- 239000004743 Polypropylene Substances 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 210000001367 artery Anatomy 0.000 description 2
- 229910001424 calcium ion Inorganic materials 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 238000005520 cutting process Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- 229920000669 heparin Polymers 0.000 description 2
- 239000002480 mineral oil Substances 0.000 description 2
- 235000010446 mineral oil Nutrition 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- 229920001155 polypropylene Polymers 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 239000012460 protein solution Substances 0.000 description 2
- 238000012797 qualification Methods 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 235000009566 rice Nutrition 0.000 description 2
- 239000007790 solid phase Substances 0.000 description 2
- 230000001026 thromboplastic effect Effects 0.000 description 2
- 210000003462 vein Anatomy 0.000 description 2
- 239000002699 waste material Substances 0.000 description 2
- 206010008132 Cerebral thrombosis Diseases 0.000 description 1
- 241000194386 Coelosis Species 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 102000009123 Fibrin Human genes 0.000 description 1
- 108010073385 Fibrin Proteins 0.000 description 1
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 1
- 206010019617 Henoch-Schonlein purpura Diseases 0.000 description 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
- 208000031814 IgA Vasculitis Diseases 0.000 description 1
- 201000001429 Intracranial Thrombosis Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- MKYBYDHXWVHEJW-UHFFFAOYSA-N N-[1-oxo-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propan-2-yl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(C(C)NC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 MKYBYDHXWVHEJW-UHFFFAOYSA-N 0.000 description 1
- 241000282373 Panthera pardus Species 0.000 description 1
- 244000261559 Smilax china Species 0.000 description 1
- 239000004809 Teflon Substances 0.000 description 1
- 229920006362 Teflon® Polymers 0.000 description 1
- 206010043561 Thrombocytopenic purpura Diseases 0.000 description 1
- 229910001069 Ti alloy Inorganic materials 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 206010000891 acute myocardial infarction Diseases 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 230000010100 anticoagulation Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 239000012295 chemical reaction liquid Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 230000001112 coagulating effect Effects 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 208000009190 disseminated intravascular coagulation Diseases 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 229950003499 fibrin Drugs 0.000 description 1
- 230000020764 fibrinolysis Effects 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 229960002897 heparin Drugs 0.000 description 1
- ZFGMDIBRIDKWMY-PASTXAENSA-N heparin Chemical compound CC(O)=N[C@@H]1[C@@H](O)[C@H](O)[C@@H](COS(O)(=O)=O)O[C@@H]1O[C@@H]1[C@@H](C(O)=O)O[C@@H](O[C@H]2[C@@H]([C@@H](OS(O)(=O)=O)[C@@H](O[C@@H]3[C@@H](OC(O)[C@H](OS(O)(=O)=O)[C@H]3O)C(O)=O)O[C@@H]2O)CS(O)(=O)=O)[C@H](O)[C@H]1O ZFGMDIBRIDKWMY-PASTXAENSA-N 0.000 description 1
- 229960001008 heparin sodium Drugs 0.000 description 1
- 208000015446 immunoglobulin a vasculitis Diseases 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000007769 metal material Substances 0.000 description 1
- 150000004702 methyl esters Chemical class 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 239000002861 polymer material Substances 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 230000003746 surface roughness Effects 0.000 description 1
- 238000010257 thawing Methods 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/483—Physical analysis of biological material
- G01N33/487—Physical analysis of biological material of liquid biological material
- G01N33/49—Blood
- G01N33/4905—Determining clotting time of blood
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/483—Physical analysis of biological material
- G01N33/487—Physical analysis of biological material of liquid biological material
- G01N33/49—Blood
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Ecology (AREA)
- Biophysics (AREA)
- Medicinal Chemistry (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Description
Claims (11)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210028312.8A CN114414790A (zh) | 2017-11-28 | 2017-11-28 | 检测液体相变的装置和方法 |
CN201711210942.2A CN109839349B (zh) | 2017-11-28 | 2017-11-28 | 检测液体相变的装置和方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201711210942.2A CN109839349B (zh) | 2017-11-28 | 2017-11-28 | 检测液体相变的装置和方法 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210028312.8A Division CN114414790A (zh) | 2017-11-28 | 2017-11-28 | 检测液体相变的装置和方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN109839349A true CN109839349A (zh) | 2019-06-04 |
CN109839349B CN109839349B (zh) | 2021-12-07 |
Family
ID=66879377
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201711210942.2A Active CN109839349B (zh) | 2017-11-28 | 2017-11-28 | 检测液体相变的装置和方法 |
CN202210028312.8A Pending CN114414790A (zh) | 2017-11-28 | 2017-11-28 | 检测液体相变的装置和方法 |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210028312.8A Pending CN114414790A (zh) | 2017-11-28 | 2017-11-28 | 检测液体相变的装置和方法 |
Country Status (1)
Country | Link |
---|---|
CN (2) | CN109839349B (zh) |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1491358A (zh) * | 2000-12-19 | 2004-04-21 | ����˹ҽ������˾ | 用于测量血液凝固的装置及其方法 |
CN101000352A (zh) * | 2007-01-17 | 2007-07-18 | 李钢 | 一种液体凝固时间的测量装置 |
CN103143405A (zh) * | 2007-09-20 | 2013-06-12 | 艾莱恩微观系统有限公司 | 确定流体凝结时间的微流体装置和方法 |
CN103383391A (zh) * | 2012-05-04 | 2013-11-06 | 北京尚位非凡医药科技有限公司 | 一种凝血时间检测装置 |
CN104501994A (zh) * | 2014-12-30 | 2015-04-08 | 深圳九星印刷包装集团有限公司 | 时间温度指示装置 |
US20160258968A1 (en) * | 2013-10-16 | 2016-09-08 | President And Fellows Of Harvard College | A microfluidic device for real-time clinical monitoring and quantitative assessment of whole blood coagulation |
CN107110874A (zh) * | 2014-09-26 | 2017-08-29 | 雅培医护站股份有限公司 | 用于测定流体样品中的凝固的传感器 |
-
2017
- 2017-11-28 CN CN201711210942.2A patent/CN109839349B/zh active Active
- 2017-11-28 CN CN202210028312.8A patent/CN114414790A/zh active Pending
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1491358A (zh) * | 2000-12-19 | 2004-04-21 | ����˹ҽ������˾ | 用于测量血液凝固的装置及其方法 |
CN101000352A (zh) * | 2007-01-17 | 2007-07-18 | 李钢 | 一种液体凝固时间的测量装置 |
CN103143405A (zh) * | 2007-09-20 | 2013-06-12 | 艾莱恩微观系统有限公司 | 确定流体凝结时间的微流体装置和方法 |
CN103383391A (zh) * | 2012-05-04 | 2013-11-06 | 北京尚位非凡医药科技有限公司 | 一种凝血时间检测装置 |
US20160258968A1 (en) * | 2013-10-16 | 2016-09-08 | President And Fellows Of Harvard College | A microfluidic device for real-time clinical monitoring and quantitative assessment of whole blood coagulation |
CN107110874A (zh) * | 2014-09-26 | 2017-08-29 | 雅培医护站股份有限公司 | 用于测定流体样品中的凝固的传感器 |
CN104501994A (zh) * | 2014-12-30 | 2015-04-08 | 深圳九星印刷包装集团有限公司 | 时间温度指示装置 |
Also Published As
Publication number | Publication date |
---|---|
CN109839349B (zh) | 2021-12-07 |
CN114414790A (zh) | 2022-04-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5977825B2 (ja) | マイクロチップを基盤とした血小板複合機能検査装置 | |
JP6091649B2 (ja) | 遠心力のマイクロ流動ベースの血小板複合機能と薬物反応検査装置 | |
KR101481240B1 (ko) | 마이크로 유동칩 기반 혈소판 기능 및 약물반응 검사 장치 및 방법 | |
CN102150042B (zh) | 血小板检验方法和血小板检验装置 | |
US7262059B2 (en) | Systems and methods for measuring fluid properties | |
CA2660381C (en) | Systems and methods for measuring fluid properties | |
US20110045993A1 (en) | Microfluidic device for assessing object/test material interactions | |
JP2014515494A (ja) | 毛細管の液体流れ測定及びそのための毛細管流れ装置 | |
CN108627636B (zh) | 检测液体凝固的装置和方法 | |
CN111289556B (zh) | 检测液体相变的装置和方法 | |
KR101749796B1 (ko) | 혈소판 검사용 칩 | |
CN111855732B (zh) | 检测液体相变的装置和方法 | |
KR101667146B1 (ko) | 혈소판 검사용 칩 및 이를 이용한 혈소판 검사 장치 | |
JP6361903B2 (ja) | 流体速度測定装置 | |
CN109839349A (zh) | 检测液体相变的装置和方法 | |
CN112924431B (zh) | 一种微流体芯片及血小板功能检测装置 | |
CN111381051A (zh) | 一种凝血激活试剂盒及其制备方法 | |
US8559007B2 (en) | Systems for measuring properties of a physiological fluid suspension | |
CN215004989U (zh) | 一种微流体芯片及血小板功能检测装置 | |
CN115672421A (zh) | 一种微流控电阻抗血小板功能检测方法和采用该方法的微芯片 | |
Yeom | Micro/Nano fluidics Based Biosensors | |
KR20230149730A (ko) | 혈전탄성도 테스트 장치 및 방법 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20240111 Address after: Room 3020, 3rd Floor, Building 1, Yard 87, Building Materials City West Road, Changping District, Beijing 102208 Patentee after: Beijing Jushu Biotechnology Co.,Ltd. Address before: Room 612, Building D, Pioneer Park, 2 Shangdi Information Road, Haidian District, Beijing 100085 Patentee before: BEIJING BICHENG BIOTECHNOLOGY Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20240905 Address after: No. 68 Meiliang Road, Mashan Street, Binhu District, Wuxi City, Jiangsu Province, 214091 East 3-105 Patentee after: Wuxi Juheyuanqi Biotechnology Co.,Ltd. Country or region after: China Address before: Room 3020, 3rd Floor, Building 1, Yard 87, Building Materials City West Road, Changping District, Beijing 102208 Patentee before: Beijing Jushu Biotechnology Co.,Ltd. Country or region before: China |
|
TR01 | Transfer of patent right |